Research Article
Analysis of Multiple Vitamins Serum Levels and Disease-Related Factors in Children with Acute Leukemia
Table 5
Analysis of factors influencing different risk degrees in children with acute leukemia.
| | Indicators | | HR group (n = 44) | IR group (n = 53) | SR group (n = 8) | F/X2 | |
| | Age | | 8.18 ± 10.83 | 8.98 ± 16.57 | 5.25 ± 2.92 | 0.261 | 0.771 | | BMI | | 16.85 ± 2.78 | 16.58 ± 2.88 | 14.43 ± 2.5 | 0.883 | 0.417 | | Gender | Male | 22 (50) | 33 (62.3) | 4 (50.0) | 1.604 | 0.448 | | Female | 22 (50) | 20 (37.7) | 4 (50.0) | | Diagnostic results | ALL | 35 (79.5) | 40 (75.5) | 7 (87.5) | 0.681 | 0.711 | | AML | 9 (20.5) | 13 (24.5) | 1 (12.5) | | Immunophenotype | AML | 8 (18.2) | 13 (24.5) | 1 (12.5) | 1.084 | 0.897 | | B | 32 (72.7) | 36 (67.9) | 6 (75.0) | | T | 4 (9.1) | 4 (7.5) | 1 (12.5) | | Liver function | Abnormal | 10 (22.7) | 16 (30.8) | 1 (12.5) | 2.119 | 0.347 | | Normal | 34 (77.3) | 36 (69.2) | 7 (87.5) | | Renal function | Abnormal | 4 (9.1) | 11 (20.8) | 4 (50.0) | 9.869 | 0.007 | | Normal | 40 (90.9) | 42 (79.2) | 4 (50.0) | | Icterus | Yes | 5 (11.4) | 8 (15.1) | 0 | 8.496 | 0.014 | | No | 39 (88.6) | 45 (84.9) | 8 (100.0) | | Biochemical indicator | Alanine aminotransferase (ALT, mmol/L) | 48.11 ± 106.33 | 31.58 ± 34.05 | 47.49 ± 36.33 | 0.641 | 0.529 | | Aspartate aminotransferase (AST, mmol/L) | 41.51 ± 50.47 | 29.78 ± 23.77 | 39.57 ± 17.33 | 1.230 | 0.297 | | Lactate dehydrogenase (LD, U/L) | 534.66 ± 1281.05 | 363.04 ± 728.54 | 303.86 ± 181.69 | 0.426 | 0.654 | | Hydroxybutyric dehydrogenase (HBDH, U/L) | 386.91 ± 841.45 | 262.06 ± 491.06 | 239.14 ± 161.26 | 0.487 | 0.616 | | Serological indicators | White blood cell count (WBC, 109/L) | 6.99 ± 11.62 | 12.37 ± 23.50 | 5.83 ± 4.62 | 1.203 | 0.304 | | Neutrophils (N, 109/L) | 3.33 ± 5.50 | 2.80 ± 4.29 | 2.72 ± 1.66 | 0.168 | 0.846 | | Hemoglobin (Hb, g/L) | 87.89 ± 18.32 | 92.45 ± 22.68 | 97.88 ± 28.54 | 0.997 | 0.373 | | Platelet count (PLT) | 125.39 ± 87.45 | 189.85 ± 132.01 | 170.63 ± 92.35 | 3.964 | 0.022 | | (PLT, 109/L) | Lymphocyte (L, 109/L) | 2.76 ± 6.16 | 6.18 ± 14.67 | 2.63 ± 3.98 | 1.224 | 0.298 | | C-reactive protein (CRP, mg/L) | 9.63 ± 25.49 | 9.15 ± 19.36 | 9.21 ± 14.44 | 0.006 | 0.994 | | Activated partial thromboplastin time (APTT, s) | 30.73 ± 7.70 | 30.61 ± 5.76 | 28.36 ± 2.57 | 0.411 | 0.664 | | Troponin (Tn) | 6.79 ± 8.58 | 5.68 ± 8.62 | 6.28 ± 11.67 | 0.192 | 0.826 | | Vitamin level | Vitamin A (VA, μmol/L) | 0.71 ± 0.18 | 0.76 ± 0.24 | 0.71 ± .24 | 0.944 | 0.392 | | Vitamin B1 (VB1, nmol/L) | 98.32 ± 13.29 | 99.91 ± 12.16 | 101.67 ± 10.33 | 0.336 | 0.715 | | Vitamin B2 (VB2, μg/L) | 5.42 ± 1.33 | 5.78 ± 2.25 | 5.50 ± 1.37 | 0.466 | 0.629 | | Vitamin B6 (VB6, nmol/L) | 34.77 ± 17.05 | 32.86 ± 13.23 | 36.43 ± 15.96 | 0.309 | 0.735 | | Vitamin B9 (VB9, nmol/L) | 20.49 ± 6.73 | 19.54 ± 5.04 | 18.14 ± 4.94 | 0.688 | 0.505 | | Vitamin B12 (VB12, pg/mL) | 484.54 ± 91.76 | 474.32 ± 90.16 | 446.55 ± 76.09 | 0.635 | 0.532 | | Vitamin C (VC, μmol/L) | 38.69 ± 5.26 | 39.22 ± 6.10 | 37.51 ± 3.45 | 0.358 | 0.700 | | Vitamin D (VD, nmol/L) | 40.85 ± 15.11 | 44.04 ± 21.09 | 36.56 ± .02 | 0.785 | 0.459 | | Vitamin E (VE, μg/mL) | 10.77 ± 0.83 | 10.62 ± 0.68 | 10.77 ± 0.87 | 0.520 | 0.596 |
|
|
Data were mean ± SD or n (%). Missing = 2. . AML, acute myeloid leukemia; BMI, body mass index; HR, high risk; IR, intermediate risk; SR, slight risk. |